Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall tone reflects enthusiasm about the therapy’s ability to expand human beta cell mass, with discussions emphasizing its potential to reverse or significantly improve diabetes, exemplified by phrases like 'significant impact' and 'breakthrough.' Posts referencing collaboration and scientific advances, such as 'City of Hope and Mount Sinai scientists,' contribute to a perception of high impact, while some comments express curiosity about its mechanisms, showing moderate interest and engagement.
Most discussions affirm the significance of the therapy and its potential for diabetes treatment, indicating general consensus.
Participants show moderate interest, interested enough to share and comment on the novelty and significance of the therapy.
Comments include references to scientific methods, collaborations, and terminology such as 'combination therapy' and 'beta cell mass,' demonstrating some depth.
Many posts highlight the potential to transform diabetes treatment, emphasizing breakthroughs and future implications, suggesting high perceived impact.
داروی جدیدی ساخته شده که تونسته با کمک بازسازی سلولهای تولیدکننده #انسولین، ظرف ۳ ماه، تولید انسولین تو موشهای دیابتی را تا ۷۰۰ درصد افزایش بده! https://t.co/s4JhnDIaqF
Excited to share our publication in Science Translational Medicine. Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system. https://t.co/TFLqLzEKYz
Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system | Science Translational Medicine https://t.co/U1bf2huLJQ
City of Hope and Mount Sinai scientists first to demonstrate a combination treatment can increase human insulin-producing cells in vivo https://t.co/CiufdrsM07 The related work is published in Science Translational Medicine. https://t.co/TFLqLzEKYz
Advances in expanding human beta cell mass #diabetes Harmine + Exendin-4 promote altered β cell proliferation, function, and survival #islets @ScienceTM https://t.co/bKT5PfmCT7
STM article from our lab is finally out!! https://t.co/qIwqvHif9u
NASA, DARPA, and Google developed Field AI for robots to coexist with humans. The video covers drone traffic tests, humanoid robot interactions, an army of robots, and the world's first mobile construction robot…
NASA, DARPA, and Google developed Field AI for robots to coexist with humans. A swarm of 5000 drones tests autonomous flight, and humanoid robots learn to greet and hug humans. These advancements highlight the future of…
Researchers developed a drug therapy that increased insulin-producing cells by 700 in diabetic mice, effectively reversing the disease. This approach combines two medications to regenerate beta cells directly in the…
https://t.co/VXeXQVKdRI
Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system | Science Translational Medicine https://t.co/4hBCnmfrHx https://t.co/sDKhwzHHpk
Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system | Science Translational Medicine https://t.co/4hBCnmfrHx https://t.co/plZXViPPnL
@armandoalducin https://t.co/aCI06pzwHQ
RT @DGArmstrong: Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system | Science T…
Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system | Science Translational Medicine https://t.co/4hBCnmfrHx https://t.co/U1LcmiKBUC
Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system | Science Translational Medicine https://t.co/4hBCnmfrHx https://t.co/T94F5l5dd3
The original paper -> https://t.co/KqtCk6NnI6
Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system | Science Translational Medicine https://t.co/1YVEW8lC4f
RT @DanielJDrucker: Advances in expanding human beta cell mass #diabetes Harmine + Exendin-4 promote altered β cell proliferation, function…
ハルミンとエキセンディン-4の併用療法は、マウス異種移植システムにおいて、体内でヒトβ細胞量を安全に増加させる https://t.co/wiqAvgZSEV インスリン細胞を700%増加させる有望な糖尿病治療が病気を逆転させる希望をもたらす。 -糖尿病患者において内因性ベータ細胞を安全な方法で増殖実現すれば凄い
Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system | Science Translational Medicine https://t.co/3RoTpOygvy
RT @AGOcanaLab_COH: Excited to share our publication in Science Translational Medicine. Harmine and exendin-4 combination therapy safely ex…
RT @AGOcanaLab_COH: Excited to share our publication in Science Translational Medicine. Harmine and exendin-4 combination therapy safely ex…
https://t.co/EBMIdPApXV
RT @AGOcanaLab_COH: Excited to share our publication in Science Translational Medicine. Harmine and exendin-4 combination therapy safely ex…
Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system | Science Translational Medicine https://t.co/4hBCnmfrHx https://t.co/M6DCxN7xfq
RT @BlueJakk: داروی جدیدی ساخته شده که تونسته با کمک بازسازی سلولهای تولیدکننده #انسولین، ظرف ۳ ماه، تولید انسولین تو موشهای دیابتی را تا ۷…
RT @BlueJakk: داروی جدیدی ساخته شده که تونسته با کمک بازسازی سلولهای تولیدکننده #انسولین، ظرف ۳ ماه، تولید انسولین تو موشهای دیابتی را تا ۷…
RT @BlueJakk: داروی جدیدی ساخته شده که تونسته با کمک بازسازی سلولهای تولیدکننده #انسولین، ظرف ۳ ماه، تولید انسولین تو موشهای دیابتی را تا ۷…
RT @BlueJakk: داروی جدیدی ساخته شده که تونسته با کمک بازسازی سلولهای تولیدکننده #انسولین، ظرف ۳ ماه، تولید انسولین تو موشهای دیابتی را تا ۷…
RT @BlueJakk: داروی جدیدی ساخته شده که تونسته با کمک بازسازی سلولهای تولیدکننده #انسولین، ظرف ۳ ماه، تولید انسولین تو موشهای دیابتی را تا ۷…
RT @BlueJakk: داروی جدیدی ساخته شده که تونسته با کمک بازسازی سلولهای تولیدکننده #انسولین، ظرف ۳ ماه، تولید انسولین تو موشهای دیابتی را تا ۷…
RT @BlueJakk: داروی جدیدی ساخته شده که تونسته با کمک بازسازی سلولهای تولیدکننده #انسولین، ظرف ۳ ماه، تولید انسولین تو موشهای دیابتی را تا ۷…
RT @BlueJakk: داروی جدیدی ساخته شده که تونسته با کمک بازسازی سلولهای تولیدکننده #انسولین، ظرف ۳ ماه، تولید انسولین تو موشهای دیابتی را تا ۷…
RT @erwinloh: #Diabetes-reversing drug boosts #insulin-producing cells by 700% Scientists have tested a new drug therapy in #diabetic mic…
RT @BlueJakk: داروی جدیدی ساخته شده که تونسته با کمک بازسازی سلولهای تولیدکننده #انسولین، ظرف ۳ ماه، تولید انسولین تو موشهای دیابتی را تا ۷…
داروی جدیدی ساخته شده که تونسته با کمک بازسازی سلولهای تولیدکننده #انسولین، ظرف ۳ ماه، تولید انسولین تو موشهای دیابتی را تا ۷۰۰ درصد افزایش بده! https://t.co/s4JhnDIaqF
#Diabetes-reversing drug boosts #insulin-producing cells by 700% Scientists have tested a new drug therapy in #diabetic mice, and found that it boosted insulin-producing cells by 700% over three months, effectively reversing their disease. https://t.co/F4E5O31cIa https://t.co/0fYnodD026
Harmine and exendin-4 combination therapy safely expands human beta cell mass in vivo in a mouse xenograft system https://t.co/T4rOX8isUB https://t.co/mx7ETIRAmt
Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system | Science Translational Medicine https://t.co/KYeXUf8ST8
RT @AGOcanaLab_COH: City of Hope and Mount Sinai scientists first to demonstrate a combination treatment can increase human insulin-produci…
RT @AGOcanaLab_COH: Excited to share our publication in Science Translational Medicine. Harmine and exendin-4 combination therapy safely ex…
RT @AGOcanaLab_COH: City of Hope and Mount Sinai scientists first to demonstrate a combination treatment can increase human insulin-produci…
RT @HayrTopcu: https://t.co/boj6cD56BM
RT @zenbrainest: Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system | Science T…
RT @DanielJDrucker: Advances in expanding human beta cell mass #diabetes Harmine + Exendin-4 promote altered β cell proliferation, function…
https://t.co/boj6cD56BM
RT @AGOcanaLab_COH: City of Hope and Mount Sinai scientists first to demonstrate a combination treatment can increase human insulin-produci…
Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system | Science Translational Medicine https://t.co/JEPYSoHK7x
RT @AGOcanaLab_COH: Excited to share our publication in Science Translational Medicine. Harmine and exendin-4 combination therapy safely ex…
RT @AGOcanaLab_COH: Excited to share our publication in Science Translational Medicine. Harmine and exendin-4 combination therapy safely ex…
RT @AGOcanaLab_COH: Excited to share our publication in Science Translational Medicine. Harmine and exendin-4 combination therapy safely ex…
RT @AGOcanaLab_COH: Excited to share our publication in Science Translational Medicine. Harmine and exendin-4 combination therapy safely ex…
RT @LickertHeiko: Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system | Science…
RT @randystyle: STM article from our lab is finally out!! https://t.co/qIwqvHif9u
RT @AGOcanaLab_COH: Excited to share our publication in Science Translational Medicine. Harmine and exendin-4 combination therapy safely ex…
RT @DanielJDrucker: Advances in expanding human beta cell mass #diabetes Harmine + Exendin-4 promote altered β cell proliferation, function…
RT @AGOcanaLab_COH: Excited to share our publication in Science Translational Medicine. Harmine and exendin-4 combination therapy safely ex…
RT @AGOcanaLab_COH: Excited to share our publication in Science Translational Medicine. Harmine and exendin-4 combination therapy safely ex…
RT @AGOcanaLab_COH: Excited to share our publication in Science Translational Medicine. Harmine and exendin-4 combination therapy safely ex…
Harmine and exendin-4 (DYRK1A inhibitor–GLP1RA) combination therapy safely expands human β cell mass in vivo in a mouse xenograft system as an approach to diabetes treatment @ScienceTM https://t.co/vRnGxuswar https://t.co/qPblphHhxl
STM article from our lab is finally out!! https://t.co/qIwqvHif9u
RT @AGOcanaLab_COH: City of Hope and Mount Sinai scientists first to demonstrate a combination treatment can increase human insulin-produci…
RT @AGOcanaLab_COH: City of Hope and Mount Sinai scientists first to demonstrate a combination treatment can increase human insulin-produci…
RT @AGOcanaLab_COH: Excited to share our publication in Science Translational Medicine. Harmine and exendin-4 combination therapy safely ex…
City of Hope and Mount Sinai scientists first to demonstrate a combination treatment can increase human insulin-producing cells in vivo https://t.co/CiufdrsM07 The related work is published in Science Translational Medicine. https://t.co/TFLqLzEKYz
RT @LickertHeiko: Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system | Science…
Excited to share our publication in Science Translational Medicine. Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system. https://t.co/TFLqLzEKYz
RT @DanielJDrucker: Advances in expanding human beta cell mass #diabetes Harmine + Exendin-4 promote altered β cell proliferation, function…
RT @DanielJDrucker: Advances in expanding human beta cell mass #diabetes Harmine + Exendin-4 promote altered β cell proliferation, function…
RT @LickertHeiko: Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system | Science…
RT @DanielJDrucker: Advances in expanding human beta cell mass #diabetes Harmine + Exendin-4 promote altered β cell proliferation, function…
RT @DanielJDrucker: Advances in expanding human beta cell mass #diabetes Harmine + Exendin-4 promote altered β cell proliferation, function…
Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system | Science Translational Medicine https://t.co/U1bf2huLJQ
Advances in expanding human beta cell mass #diabetes Harmine + Exendin-4 promote altered β cell proliferation, function, and survival #islets @ScienceTM https://t.co/bKT5PfmCT7